From insulin to Ozempic, history of Novo Nordisk’s CEOs
(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the...
(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the...
By Lisa Baertlein, Farah Master and Casey Hall LOS ANGELES/HONG KONG (Reuters) -Container ship bookings...
(Reuters) -Coinbase said on Thursday it strongly believes a regulatory investigation by the U.S. securities...
(Reuters) -Uber Technologies on Wednesday unveiled a range of new offerings such as shared fixed-route...
(Reuters) -Smartphone shipments to the U.S. surged 30% in March as manufacturers Apple, Samsung and...
(Reuters) – Advanced Micro Devices on Wednesday announced a new $6 billion stock buyback plan,...
(Reuters) -A number of U.S. technology firms on Tuesday announced artificial intelligence deals in the...
By David Shepardson NEW YORK (Reuters) -United Airlines may not take delivery of the Boeing...
(Reuters) -The volume of processors Intel is set to produce for external customers using its...
By Suzanne McGee (Reuters) -Fidelity trading platforms experienced outages just as U.S. stock markets opened...